Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study.
Wiegers H, Hamulyák EN, Damhuis SE, van Duuren JR, Darwish Murad S, Scheres L, Gordijn SJ, Leentjens J, Duvekot JJ, Lauw MN, Hutten BA, Middeldorp S, Ganzevoort W. Wiegers H, et al. Among authors: scheres l. BJOG. 2022 Mar;129(4):608-617. doi: 10.1111/1471-0528.16915. Epub 2021 Oct 4. BJOG. 2022. PMID: 34520620 Free PMC article.
Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.
Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A. Scheres L, et al. BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20. BJOG. 2018. PMID: 29940089 Free PMC article. Clinical Trial.
Concerns about the ALIFE2 trial - Authors' reply.
Quenby S, Ewington L, Hamulyák E, Scheres LJ, Goddijn M, Middeldorp S. Quenby S, et al. Among authors: scheres lj. Lancet. 2024 Jan 20;403(10423):248. doi: 10.1016/S0140-6736(23)02336-X. Lancet. 2024. PMID: 38245246 No abstract available.
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.
Quenby S, Booth K, Hiller L, Coomarasamy A, de Jong PG, Hamulyák EN, Scheres LJ, van Haaps TF, Ewington L, Tewary S, Goddijn M, Middeldorp S; ALIFE2 Block Writing Committee; ALIFE2 Investigators. Quenby S, et al. Among authors: scheres lj. Lancet. 2023 Jul 1;402(10395):54-61. doi: 10.1016/S0140-6736(23)00693-1. Epub 2023 Jun 1. Lancet. 2023. PMID: 37271152 Clinical Trial.
Effectiveness and cost-effectiveness of MicroShunt implantation versus standard trabeculectomy for open-angle glaucoma (a SIGHT study): study protocol of a multicentre randomised controlled trial.
Scheres LMJ, van den Biggelaar FJHM, Winkens B, Kujovic-Aleksov S, Müskens RPHM, de Waard PWT, de Crom RMPC, Ernest PJG, Pijl BJ, Ramdas WD, van Rijn LJ, Tan A, Dirksen CD, Beckers HJM. Scheres LMJ, et al. BMC Ophthalmol. 2023 Jan 31;23(1):43. doi: 10.1186/s12886-022-02734-y. BMC Ophthalmol. 2023. PMID: 36721130 Free PMC article.
Risk of venous thromboembolism in women with endometriosis.
Wiegers HMG, Scheres LJJ, Tahir L, Hutten BA, Middeldorp S, Mijatovic V. Wiegers HMG, et al. Among authors: scheres ljj. Thromb Res. 2022 Sep;217:104-106. doi: 10.1016/j.thromres.2022.07.014. Epub 2022 Aug 1. Thromb Res. 2022. PMID: 35932497 No abstract available.
70 results